Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

Andreas Doesch, Repp, Hofmann, Erbel, Frankenstein, Gleissner, Constanze Schmidt, Ruhparwar, Zugck, Schnitzler, Ehlermann, Dengler, Katus
  • Drug Design Development and Therapy, October 2012, Taylor & Francis
  • DOI: 10.2147/dddt.s36578

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/dddt.s36578

The following have contributed to this page: Christian Gleißner and Hugo Katus